schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals."
.
david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation.
.
.
the publication�s purpose is to be a "force for good and a platform for much needed change and to generate critical debate".
.